The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

Dartmouth Health

Status: Completed

Conditions: Multiple Sclerosis

Treatments: Other: Quality Improvement

Study type: Interventional

Funder types: Other

Identifiers

NCT03480854

US-MSG-15-10917 (Other Grant/Funding Number)

D16181

Details and patient eligibility

About

To establish the first systems level continuous quality improvement (CQI) collaborative for multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and assessments of geographic variation in MS care quality and value, and study the effect of CQI interventions on improvement of selected performance (quality) indicators.

Full description

This is a three year study which employed a step-wedge randomized design which exposed three of four participating centers to a healthcare QI intervention during the 3 year period. Each of the centers exposed to an intervention served as its own control during a baseline pre-intervention period during the first year of the study. The fourth site served as a longitudinal control for comparison to the other three centers exposed to a QI intervention.

Enrollment: 694 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults aged 18 years or older with documented clinically confirmed MS who are followed by one of the participating MS centers.

Exclusion criteria

• Candidates will be excluded from study entry if they are unable or unwilling to provide informed consent.

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

694 participants in 2 patient groups

Baseline Analysis

No Intervention group

Description:

To conduct studies of variation in performance across microsystems and to utilize benchmarking analyses to identify top performers.

The effect of continuous quality improvements (CQI)

Experimental group

Description:

To study the comparative improvement of selected primary process performance indicators (DMT and MRI process measures) over a 3 year period (Years 2-3) in microsystems receiving CQI interventions versus those not receiving CQI intervention, and between two different CQI intervention types (IHI Breakthrough Series and Patient Centered Medical Home).

Treatment:

Other: Quality Improvement